Close watch on new substance in weight-loss products

Close watch on new substance in weight-loss products

A lab official at the Department of Medical Sciences conducts a test on samples of food supplements. Desoxy-D2PM, which remains an uncontrolled stimulant psychoactive substance, has been found in four slimming products so far. (Photo courtesy of Department of Medical Sciences)
A lab official at the Department of Medical Sciences conducts a test on samples of food supplements. Desoxy-D2PM, which remains an uncontrolled stimulant psychoactive substance, has been found in four slimming products so far. (Photo courtesy of Department of Medical Sciences)

The Department of Medical Sciences has kept a close watch on a new psychoactive substance detected in weight loss products in Thailand.

Desoxy-D2PM was found for the first time in Thailand in dietary supplements in September last year by the 10th Regional Medical Science Centre in Ubon Ratchathani, department director-general Sukhum Karnchanapimai said on Friday.

The department has since monitored the use of the substance closely and detected the presence of desoxy-D2PM in another four slimming products. It has also been found in dietary supplements exported to the US and Hong Kong, Dr Sukhum said.

Desoxy-D2PM is structurally similar to amphetamine-like compounds with stimulant effects on the central nervous system. It has appetite-suppressing, and euphoric effects, he said.

It is sold as a designer drug and has been used in the manufacture of so-called legal highs.

Overdose of desoxy-D2PM may lead to violent behaviours and hallucinations. It also affects the nervous system, the heart and drives up blood pressure, leading to death, he said.

Desoxy-D2PM is banned in the UK and Sweden, though it remains uncontrolled in Thailand. The department has raised the issue with the Food and Drug Administration to list it as a Type-1 psychotropic substance which needs to be strictly controlled by the FDA, Dr Sukhum said.

Do you like the content of this article?
COMMENT (9)